CAR-20
Cartalax 20mg
SHORT DESCRIPTION
Cartalax Peptide (Ala-Glu-Asp)
Cartalax is a short-chain bioregulatory peptide designed to act as a "biological reset" for cartilage and connective tissues.
(Please do the effort, and refer to the GLOW stack as they synergistically work together - elevating results achieved together, way higher, as opposed to either on its own)
Mechanism of Operation
Cartalax functions as a bioregulator at the epigenetic level. It penetrates the cell nucleus and interacts with specific DNA sequences, particularly the minor groove, to modulate gene expression.
Chondrocyte Activation: It stimulates the proliferation of chondrocytes (cartilage cells) and boosts the synthesis of type XI collagen.
Gene Regulation: It reduces the expression of pro-aging markers like p53 (which triggers cell death) and MMP-9 (an enzyme that breaks down the extracellular matrix).
Anti-Inflammatory: It lowers oxidative stress and inflammatory cytokines within the joint environment.
Pros & Cons
Pros ConsHigh Specificity: Directly targets cartilage cells without systemic hormonal disruption.
Limited Human Data: Most evidence stems from animal models and Russian clinical studies.
Epigenetic Repair: Addresses the root cause of tissue aging rather than just symptoms.
Regulatory Status: Sold primarily for "research use" and not FDA-approved.
Low Toxicity: Generally well-tolerated with a favorable safety profile in trials
Cost/Accessibility: Can be expensive and requires sourcing from reputable peptide vendors.
Safety
Cartalax is considered a very safe "short peptide" because it mimics natural amino acid sequences already present in human collagen. (Medical News Today)
Side Effects:
Rare, but may include mild injection site reactions or transient nausea.
Precautions:
Consult a provider at Scale Regenerative Health or Drip Hydration to ensure proper dosing and avoid interactions with existing conditions. (Prisk Orthopaedics and Wellness)
This product is for research purposes only and is NOT for human consumption. Intended for use by qualified researchers and institutions only.
RESEARCH AND PRACTICAL APPLICATIONS
Cartalax Peptide (Ala-Glu-Asp)
For Joint Pain, Back Pain, Elbows, Knees, Neck - and especially for people on GLP's targeting aggressive weight loss - usually starting at a high BMI, the goal of a bioregulator cycle is to provide a "structural foundation" so that the regenerative peptides (like BPC-157/TB-500, paired with GHK-Cu) have healthy cellular material to work with.
Practical Application & Example Conditions
It is primarily used to treat degenerative joint diseases and age-related wear and tear. Like all peptides, it works well, but exponentially better, when used in conjunction with another synergistic peptide, both boosting the other.
Example Conditions: Osteoarthritis, rheumatoid arthritis, degenerative disc disease (DDD), and recovery from tendon or ligament tears in sports injuries.
Osteoarthritis: Slowing joint degradation and easing chronic pain.
Sports Recovery: Healing from meniscus tears, ligament strain, or "overuse" injuries.
Spinal Support: Addressing degenerative disc issues or stiffness.
Systemic Anti-Aging: Protecting kidney and skin health by maintaining extracellular matrix density.
The 20-Day Cartalax "Joint & Cartilage" Reset Cycle
This protocol focuses on using Cartalax to prime chondrocytes, followed by a maintenance phase.
What to Expect & Timeline
Unlike immediate painkillers, Cartalax is a slow-acting regenerative tool.
Weeks 1–2: Initial reduction in systemic inflammation and "morning stiffness."
Weeks 4–8: Noticeable improvement in joint mobility and weight-bearing capacity.
Maintenance: Often taken in cycles (e.g., 10–20 days twice a year) to maintain cellular renewal. (Medical News Today)
Phase 1: Priming (Days 1–10)
The objective is to achieve a high enough concentration to trigger epigenetic gene expression in cartilage tissue.
Cartalax Dosage: Typically 10 mg daily.
Administration: Oral capsules (2 x 5mg) or subcutaneous injection (as directed by a specialist).
What’s happening: Cartalax enters the cell nuclei of cartilage tissue, signaling for the production of new collagen and reducing the activity of enzymes that break down your joints.
Phase 2: Consolidation (Days 11–20)
Thrshrshe objective shifts to maintaining the signal while the body begins the actual repair work.
Cartalax Dosage: Reduce to 5 mg daily.
Synergy: This is the ideal window to ensure you are also using your Glow Stack (BPC-157/TB-500/GHK-Cu). - While Cartalax "resets" the cells, BPC-157 provides the "fuel" and blood flow needed for the actual reconstruction of the tissue. TB-500 ensures the material to build & restore with, and GHK-Cu synergistically also boosts not only skin elasticity, but also pushes Collagen production and correct application thereof.
Phase 3: The "Washout" & Maintenance (Months 1–6)
Peptide bioregulators are not designed for year-round use. They create a "prolongation effect" that lasts long after the last dose.
Duration: Stop Cartalax after Day 20.
Expectation: You may not feel a "burst" of relief on Day 5, but by Day 40, users typically report significantly smoother joint "glide" and less clicking/popping.
Frequency: Repeat this 20-day cycle once every 3 to 6 months.
Optimization Checklist
To get the most out of this cycle, especially with a high BMI, consider these boosters:
Vitamin C (500mg - 1g daily): A critical cofactor for the collagen synthesis that Cartalax is trying to trigger.
Hydration: Peptides require a highly hydrated environment to facilitate cellular signaling.
Low-Impact Movement: Engaging in swimming or cycling during the "Consolidation" phase helps drive the newly produced synovial fluid into the joint capsule.
Proper sleep hygiene: The usual mantra with all peptides.. Sleep 6-9hrs
Peptide Therapy vs. Clinical Protocols
Standard clinical protocols (like Cortisone shots or Ibuprofen - each having their various negative side effects) focus on inflammation suppression, which does inhibit long-term tissue remodeling. Peptide therapy focuses on biological restoration, addressing the underlying structural issues by stimulating the body’s innate repair mechanisms without the hormonal or gastrointestinal risks often associated with traditional pharmacological agents.
Research Use Only
These instructions are for research purposes. Use under medical professional supervision.
